Molence (@MolenceBio) header
Molence (@MolenceBio) profile picture
Joined October 2026
Photo by Molence (@MolenceBio)Photo by Molence (@MolenceBio)Photo by Molence (@MolenceBio)Photo by Molence (@MolenceBio)Photo by Molence (@MolenceBio)Photo by Molence (@MolenceBio)Photo by Molence (@MolenceBio)Photo by Molence (@MolenceBio)Photo by Molence (@MolenceBio)
Introducing Mol-1: Open Frontier Biomolecular Intelligence 🚀🚀🚀 📊 75.0% on FoldBench-AB, near IsoDDE's reported 75.58%!!! 🧬 60k-token assemblies on one single H20, outperforming Anthropic 8/10. 🎯 VHHs binding hit rate as high as 63% with best SPR KD at 43 pM. GitHub: github.com/molence/Mol-1 Try it: lab.molence.com
16
100
13
592
62,845
Mol-1 agent: large protein assemblies on a single NVIDIA H20, outperforming Anthropic 9/10. In our 10-case evaluation (8,000-60,120 residues), 8 assemblies reached TM-score ≥0.9. The five 30K-60K-residue capsid cases scored 0.993-0.999; Anthropic's published runs for these cases produced collapsed structures. The ~10K group is mixed: Mol-1 has higher reported TM-scores on 4 of 5 cases, but is lower on 7UTD (0.478 vs 0.96). These results come from a long-running, iterative prediction-and-assembly workflow, taking tens of hours. The figure compares published results under different hardware and inference settings; it is not a controlled head-to-head benchmark. Reports: Mol-1: github.com/molence/Mol-1/blo… Anthropic: anthropic.com/research/claud…
1
10
85
4,190
1/15 🧬 Mol-1 on antibody structure prediction: on par with IsoDDE, open to build on. 75.0% median success at DockQ > 0.23, on par with IsoDDE’s reported 75.58%. Across all 201,376 five-seed combinations from 32 seeds, 62.22% matched or exceeded 75% success—showing robust performance across seed selections. We release the model code and weights so researchers can run Mol-1 in their own environment and build on its capabilities. Code & weights: github.com/molence/Mol-1 Try Mol-1: lab.molence.com #AIforScience #DrugDiscovery
3
8
6
42
6,243
14/15 📍 Bring epitope knowledge into structure prediction. With epitope information, Mol-1-constraint improves antibody–antigen success at DockQ > 0.23 across all four benchmarks: • FoldBench-AB: 75.0% → 88.3% • AF3-AB: 62.7% → 84.2% • PXMeter-AB: 58.3% → 77.5% • MolBench-AB-26: 57.3% → 79.4% Evaluate Mol-1 and Mol-1-constraint with your own biological questions: lab.molence.com #AIforScience
1
2
139
15/15 📍 Three residues can provide a useful structural clue. In three case studies, we supplied three-residue site hypotheses informed by literature and monomer structures. With Mol-1-constraint, DockQ improved: • 0.014 → 0.874 • 0.011 → 0.739 • 0.200 → 0.863 These examples show how sparse biological hypotheses can guide complex prediction. #AIforScience
1
133